Search results
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 11 hours agoThose who stayed on Zepbound lost an additional 5.5% of their weight. In another analysis of...
New rules mean 3.6 million Americans could get Wegovy via Medicare, costing billions
Medical Xpress· 6 days agoThe FDA's ruling potentially allows Wegovy prescription coverage for more than a quarter of 13.7...
KFF Analysis Finds an Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be...
Sierra Sun Times· 6 days agoIn a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of...
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance· 1 day ago"I can't of anything where there's just been a couple of under-patent drugs competing where that...
Bernie Sanders Is Taking on Ozempic’s ‘Astronomically High’ Price Tag
Gizmodo via Yahoo News· 4 days agoSenator Bernie Sanders (I-VT) is taking aim at one of Big Pharma’s newest cash cows: the latest...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 5 hours agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster...
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
CNBC· 6 days agoThe U.S. Senate has launched an investigation into the high price of Novo Nordisk's popular weight...
Millions of Medicare recipients could gain access to weight-loss drug
Newsweek· 7 days agoMillions of overweight or obese patients with heart conditions insured under Medicare could gain...
Opinion | This Is What a Miracle Drug Looks Like, and It Costs Only $5 to Make
New York Times· 6 days agoLast year was called the year of Ozempic, though it was also a year of Ozempic backlash and Ozempic...
Novo Nordisk: Growth Is Still A Better Choice
GuruFocus.com via Yahoo Finance· 2 days agoSince the beginning of 2024, the company's share price has risen more than 20% thanks to hype around the new wave of weight loss agents, as well as...